BBA
Baker Bros. Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,271,917
| Closed | -$144M | – | 124 |
|
|
2021
Q2 | $144M | Buy |
2,271,917
+597,913
| +36% | +$37.8M | 0.63% | 16 |
|
|
2021
Q1 | $71.8M | Buy |
1,674,004
+777,453
| +87% | +$33.4M | 0.31% | 31 |
|
|
2020
Q4 | $51.3M | Hold |
896,551
| – | – | 0.19% | 34 |
|
|
2020
Q3 | $27M | Hold |
896,551
| – | – | 0.11% | 44 |
|
|
2020
Q2 | $29.3M | Hold |
896,551
| – | – | 0.13% | 41 |
|
|
2020
Q1 | $24M | Buy |
896,551
+399,582
| +80% | +$10.7M | 0.15% | 38 |
|
|
2019
Q4 | $15.2M | Buy |
496,969
+183,244
| +58% | +$5.61M | 0.08% | 49 |
|
|
2019
Q3 | $7.56M | Hold |
313,725
| – | – | 0.05% | 55 |
|
|
2019
Q2 | $7.95M | Hold |
313,725
| – | – | 0.05% | 57 |
|
|
2019
Q1 | $6.12M | Buy |
313,725
+117,647
| +60% | +$2.29M | 0.04% | 56 |
|
|
2018
Q4 | $2.59M | Hold |
196,078
| – | – | 0.02% | 68 |
|
|
2018
Q3 | $3.49M | Hold |
196,078
| – | – | 0.02% | 79 |
|
|
2018
Q2 | $4.31M | Buy |
+196,078
| New | +$4.31M | 0.03% | 83 |
|